Blog

Sridhar Radhakrishnan, Steven F Yeung, Jia-Yu Ke, Maísa M Antunes, Michael A Pellizzon
Current Developments in Nutrition, Volume 5, Issue 12, December 2021

The COVID-19 pandemic has caused millions of deaths worldwide and caused significant impact on the global economy. The risk of severe coronavirus disease 2019 (COVID-19) is higher in people with diabetes and obesity. The exact mechanism by which obesity and diabetes contribute to the pathophysiology of COVID-19 is unknown and one of the key player is believed to be related to the renin-angiotensin system (RAS).

Join Dr. Mike Pellizzon for his presentation at the Swiss Laboratory Animal meeting this Friday. Diet is an important consideration when designing your rodent studies for gut microbiome research; in particular, fiber is a key factor that can drive changes.

Rodent Diet With 40 kcal% Fat (Mostly Palm Oil), 20 kcal% Fructose and 2% Cholesterol(D09100310) has been tested by the Danish contract research organization, Gubra, and is also referred to as the Gubra-Amlyin NASH (GAN) diet in the literature.

This important question will be addressed at a special session during NUTRITION 2021 LIVE ONLINE, June 9, 2021 from 2:00 – 3:30 PM EDT. Michael A. Pellizzon, PhD from Research Diets, Inc. is presenting.

The ease of modifying purified diets, with amino acids as the protein source, allowed to make such formulations that could be used in lieu of complex procedures like myeloablation and could make the process of HSCs engraftment an easy procedure in rodents.

Despite evidence suggesting that natural products protect against obesity and metabolic syndrome in cell culture and animal models, results oftentimes do not translate in human clinical trials. One possible explanation for this finding is the...

An interesting publication using NASH diets ...

A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology

Anita M. van den Hoek 1,*, Lars Verschuren 2, Nicole Worms 1, Anita van...

Sridhar Radhakrishnan, Jia-Yu Ke, Michael A Pellizzon
Current Developments in Nutrition, Volume 4, Issue 6, June 2020

ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) is a complex spectrum of disorders ranging from simple benign steatosis to more...

Michael A Pellizzon and Matthew R Ricci
Research Diets, Inc, New Brunswick, NJ, USA

ABSTRACT
The reproducibility of experimental data is challenged by many factors in both clinical and preclinical research. In preclinical studies, several factors...